How big is the China In Vitro Diagnostics Market?

The China In Vitro Diagnostics Market size is expected to reach USD 10.61 billion in 2024 and grow at a CAGR of 6.14% to reach USD 14.86 billion by 2029. Read More

What is the current China In Vitro Diagnostics Market size?

In 2024, the China In Vitro Diagnostics Market size is expected to reach USD 10.61 billion. Read More

Who are the key players in China In Vitro Diagnostics Market?

Autobio Diagnostics, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Maccura Biotechnology and Xiamen Boson Biotech are the major companies operating in the China In Vitro Diagnostics Market. Read More

What years does this China In Vitro Diagnostics Market cover, and what was the market size in 2023?

In 2023, the China In Vitro Diagnostics Market size was estimated at USD 9.96 billion. The report covers the China In Vitro Diagnostics Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the China In Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the key growth areas in the China IVD Market?

The key growth areas in the China IVD Market are a) Molecular diagnostics b) Immunoassays c) POCT (point-of-care testing) for rapid diagnoses Read More

What are the key growth drivers for the IVD market in China?

The key growth drivers for the IVD market in China are a) Rising healthcare spending b) Aging population c) Increasing focus on early disease detection Read More

China in Vitro Diagnostics Market Trends | Industry Analysis, Size & Forecast Report

China In-vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers China In-Vitro Diagnostics Companies and the Market is Segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, and Other Types), Product (Instrument, Reagent, and Other Products), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Other Applications), and End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users). The Values are Provided in Terms of USD for Above Segments.

China In-vitro Diagnostics (IVD) Industry Overview

The Chinese in vitro diagnostic market is moderately competitive and consists of some major players. Many players in this market are trying to expand their product portfolios in order to increase their global market share. These companies focus on strategies such as mergers and acquisitions, collaborations, and new product developments. Key players in the Chinese in vitro diagnostics market are Abbott Laboratories, Shanghai Kehua Bio-Engineering Co., Ltd., Autobio Diagnostics Co., Mindray Medical International Limited, and Maccura Biotechnology, among others.